Find clinical trials for Triple Negative Breast Cancer in Berlin, BE
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near Berlin, BE, DEU:
This study will assess the efficacy and safety of Niraparib in participants with either tumor mutation in the BRCA gene (tBRCAmut) HER2- breast...
Phase 3
Berlin, Germany and 226 other locations
previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors do no...
Phase 3
Berlin, Germany and 506 other locations
with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors ...
Phase 3
Berlin, Germany and 508 other locations
with stage I to III TNBC with residual invasive disease in the breast and/or axillary lymph nodes at surgical resection following neoadjuvan...
Phase 3
Berlin, Germany and 357 other locations
vs placebo as adjuvant therapy in participants who have triple negative breast cancer (TNBC).After a screening ph...
Phase 3
Berlin, Germany and 192 other locations
combination with standard of care treatment in subjects with solid cancer tumors.Following completion of the first part, the dose escalation...
Phase 1, Phase 2
Berlin, Germany and 24 other locations
besides treating your disease.Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be removed w...
Phase 1
Berlin, Other, Germany and 22 other locations
Phase III, prospective, multi-center, randomized, open label, parallel group, study in patients with HER2-negative breast cancer...
Phase 3
Berlin, Brandenburg, Germany and 178 other locations
does to the body besides treating the disease.Participants will have cancer that has spread in the body near where it started (locally advan...
Phase 1
Berlin, Other, Germany and 17 other locations
The objective of this study is to assess safety and efficacy of CAB-ROR2-ADC in solid tumors
Phase 1, Phase 2
Berlin, Germany and 65 other locations
Clinical trials
Research sites
Resources
Legal